Characterization of effector memory CD8+ T cells in the synovial fluid of rheumatoid arthritis

Journal of Clinical Immunology

Volumn 32, Issue 4, 2012, Pages 709-720

  Cho, Bon A ^a,b   Sim, Ji Hyun ^a   Park, Ji Ah ^a   Kim, Hye Won ^a   Yoo, Wan Hee ^c   Lee, Seung Hyun ^d   Lee, Dong Sup ^a   Kang, Jae Seung ^a   Hwang, Young Il ^a   Lee, Wang Jae ^a   Kang, Insoo ^e   Lee, Eun Bong ^a   Kim, Hang Rae ^a  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Jeonbuk National University Medical School and Hospital   (South Korea)

^d Konkuk University   (South Korea)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Effector memory cells; Human CD8+ Tcells; Rheumatoid arthritis; Type 2 CD8+ Tcells

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR4; FAS ANTIGEN; GRANZYME B; INTERLEUKIN 4; KI 67 ANTIGEN; PERFORIN; PROGRAMMED DEATH 1 RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EFFECTOR MEMORY CD8+ T CELL; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SUPPRESSOR CELL; SYNOVIAL FLUID;

ANTIGENS, CD80; ANTIGENS, CD86; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRANZYMES; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PERFORIN; PROGRAMMED CELL DEATH 1 RECEPTOR; SYNOVIAL FLUID;

EID: 84863986199     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9674-3     Document Type: Article

References (46)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356-61. Epub 2003/05/16. (Pubitemid 40852711)
2. Andersson AK, Li C, Brennan FM. Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther. 2008;10(2):204. Epub 2008/04/01.
3. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429-42. Epub 2007/05/26. (Pubitemid 46834849)
4. Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 1997;40 (4):598-609. Epub 1997/04/01.
5. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998;101(4):746-54. Epub 1998/03/21. (Pubitemid 28096070)
6. Chabaud M, Fossiez F, Taupin JL,Miossec P. Enhancing effect of IL- 17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol. 1998;161(1):409-14. Epub 1998/07/01. (Pubitemid 28285549)
7. Keystone E. Treatments no longer in development for rheumatoid arthritis. Ann Rheum Dis. 2002;61 Suppl 2:ii43-5. Epub 2002/10/16.
8. Moreland LW, Alten R, Van den Bosch F, Appelboom T, Leon M, Emery P, et al. Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y 85 days after the first infusion. Arthritis Rheum. 2002;46(6):1470-9. Epub 2002/07/13. (Pubitemid 34620192)
9. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med. 1997;186(4):613-8. Epub 1997/08/18. (Pubitemid 27360805)
10. Huseby ES, Liggitt D, Brabb T, Schnabel B, Ohlen C, Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J Exp Med. 2001;194(5):669-76. Epub 2001/09/06. (Pubitemid 32844776)
11. Banerjee S,Webber C, Poole AR. The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol. 1992;144(2):347-57. Epub 1992/10/15.
12. Jiang H, Zhang SI, Pernis B. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science. 1992;256 (5060):1213-5. Epub 1992/05/22.
13. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol. 2004;5(5):516-23. Epub 2004/04/21. (Pubitemid 38660464)
14. Colovai AI, Liu Z, Ciubotariu R, Lederman S, Cortesini R, Suciu-Foca N. Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28- T cells. Transplantation. 2000;69(7):1304-10. Epub 2000/05/08. (Pubitemid 30238715)
15. Konya C, Goronzy JJ, Weyand CM. Treating autoimmune disease by targeting CD8(+) T suppressor cells. Expert Opin Biol Ther. 2009;9(8):951-65. Epub 2009/06/16.
16. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol. 1999;113(5):752-9. Epub 1999/11/26.
17. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998;187(1):129-34. Epub 1998/01/31. (Pubitemid 28044828)
18. Inaoki M, Sato S, Shirasaki F, Mukaida N, Takehara K. The frequency of type 2 CD8+ T cells is increased in peripheral blood from patients with psoriasis vulgaris. J Clin Immunol. 2003;23 (4):269-78. Epub 2003/09/10. (Pubitemid 36870669)
19. Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med. 2002;195(6):695-704. Epub 2002/03/20. (Pubitemid 34259715)
20. Masuko-Hongo K, Sekine T, Ueda S, Kobata T, Yamamoto K, Nishioka K, et al. Long-term persistent accumulation of CD8+ T cells in synovial fluid of rheumatoid arthritis. Ann Rheum Dis. 1997;56(10):613-21. Epub 1997/12/06. (Pubitemid 27444646)
21. Hall FC, Thomson K, Procter J, McMichael AJ, Wordsworth BP. TCR beta spectratyping in RA: Evidence of clonal expansions in peripheral blood lymphocytes. Ann Rheum Dis. 1998;57(5):319-22. Epub 1998/09/19. (Pubitemid 28351102)
22. Hingorani R,Monteiro J, Furie R, Chartash E, Navarrete C, Pergolizzi R, et al. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. J Immunol. 1996;156 (2):852-8. Epub 1996/01/15.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-24. Epub 1988/03/01. (Pubitemid 18091653)
24. Prevoo ML, Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, Vande Putte LB, Van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44-8. Epub 1995/01/01.
25. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708-12. Epub 1999/10/28.
26. Kim HR, Hong MS, Dan JM, Kang I. Altered IL-7Ralpha expression with aging and the potential implications of IL-7 therapy on CD8+ T-cell immune responses. Blood. 2006;107(7):2855-62. Epub 2005/12/17.
27. Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, et al. Four functionally distinct populations of human effectormemory CD8+ T lymphocytes. J Immunol. 2007;178(7):4112-9. Epub 2007/03/21. (Pubitemid 46492360)
28. Koch S, Larbi A, Derhovanessian E, Ozcelik D, Naumova E, Pawelec G. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing. 2008;5:6. Epub 2008/07/29.
29. Abe K, Takasaki Y, Ushiyama C, Asakawa J, Fukazawa T, Seki M, et al. Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus. J Clin Immunol. 1999;19(1):58-66. Epub 1999/03/18. (Pubitemid 29113333)
30. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077):682-7. Epub 2005/12/31. (Pubitemid 43237609)
31. Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, O'Shea MA, et al. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol. 2008;181(10):6738-46. Epub 2008/11/05.
32. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95- induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 1996;5(1):7-16. Epub 1996/07/01. (Pubitemid 26254781)
33. Peng SL. Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology (Oxford). 2006;45(1):26-30. Epub 2005/09/15. (Pubitemid 43033870)
34. Judge AD, Zhang X, Fujii H, Surh CD, Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memoryphenotype CD8(+) T cells. J Exp Med. 2002;196(7):935-46. Epub 2002/10/09.
35. Kim HR, Hwang KA, Kang I. Dual roles of IL-15 in maintaining IL-7RalphalowCCR7- memory CD8+ T cells in humans via recovering the phosphatidylinositol 3-kinase/AKT pathway. J Immunol. 2007;179(10):6734-40. Epub 2007/11/06.
36. Vallejo AN, Nestel AR, Schirmer M, Weyand CM, Goronzy JJ. Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem. 1998;273(14):8119- 29. Epub 1998/05/09. (Pubitemid 28168866)
37. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997;186(9):1407-18. Epub 1997/11/14. (Pubitemid 27479800)
38. Appay V, Zaunders JJ, Papagno L, Sutton J, Jaramillo A,Waters A, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol. 2002;168(11):5954-8. Epub 2002/05/23.
39. Alves NL, Arosa FA, van Lier RA. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells. J Immunol. 2005;175 (2):755-62. Epub 2005/07/09. (Pubitemid 41094956)
40. Vossen MT, Matmati M, Hertoghs KM, Baars PA, Gent MR, Leclercq G, et al. CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol. 2008;180(6):3739-45. Epub 2008/03/07.
41. Harada S, Yamamura M, Okamoto H, Morita Y, Kawashima M, Aita T, et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1999;42(7):1508-16. Epub 1999/07/14. (Pubitemid 30265610)
42. McInnes IB, al-Mughales J, Field M, Leung BP, Huang FP, Dixon R, et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med. 1996;2(2):175-82. Epub 1996/02/01. (Pubitemid 26057554)
43. Verwilghen J, Lovis R, De Boer M, Linsley PS, Haines GK, Koch AE, et al. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J Immunol. 1994;153(3):1378-85. Epub 1994/08/01. (Pubitemid 24228530)
44. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2001;2(3):261-8. Epub 2001/02/27. (Pubitemid 33706004)
45. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol. 2007;8(3):239-45. Epub 2007/02/17. (Pubitemid 46745373)
46. Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, Kemeny DM. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood. 2000;95 (1):231-40. Epub 1999/12/23. (Pubitemid 30017247)